Back
Neurocrine Biosciences Vs. The Cooper Companies Industry Stock Comparison
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
127.03
Seasonality Move:
17.1%
Buy
56
COO
The Cooper Companies
Last Price:
102.34
Seasonality Move:
6.05%
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $125.65. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
The Cooper Companies (COO)
is a Buy
Is The Cooper Companies a Buy, Sell or Hold?
- The current The Cooper Companies [COO] share price is $100.80. The Score for COO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- COO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $125.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight selling pressure.
COO Stock Price Chart
What is The Cooper Companies's stock price today?
-
The The Cooper Companies share price today is $100.80
The current trend is relatively stagnant and COO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.09 | Buy |
Relative Strength Index (14 RSI): | 58.45 | Buy |
Chaikin Money Flow: | -36833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (117.05 - 125.11) | Buy |
Bollinger Bands (100): | (116.14 - 144.06) | Sell |
COO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.71 | Sell |
Relative Strength Index (14 RSI): | 39.62 | Sell |
Chaikin Money Flow: | 604519 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.71 - 106.09) | Sell |
Bollinger Bands (100): | (92.94 - 108.18) | Buy |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.06 | Buy |
20-day SMA: | 122.35 | Buy |
50-day SMA: | 118.69 | Buy |
200-day SMA: | 133.44 | Sell |
8-day EMA: | 123.06 | Buy |
20-day EMA: | 121.92 | Buy |
50-day EMA: | 122.46 | Buy |
200-day EMA: | 127.9 | Sell |
COO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.96 | Buy |
20-day SMA: | 102.6 | Sell |
50-day SMA: | 105.92 | Sell |
200-day SMA: | 97.75 | Buy |
8-day EMA: | 100.45 | Buy |
20-day EMA: | 102.19 | Sell |
50-day EMA: | 103.3 | Sell |
200-day EMA: | 98.37 | Buy |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $1.13 per share.
The Cooper Companies Earnings Growth & COO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.42 per share.
Neurocrine Biosciences Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
The Cooper Companies Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |